Shahram Lavasani

Founder & CEO

Founder & Chief Executive Officer (CEO),ImmuneBiotech. Exploring ways to induce termination of chronic inflammatory disorders by introducing novel and innovative immunotherapies. Consulting and CRO-related services.

Senior researcher, Lund University
Performed research work in the field of Medical Inflammation Research since 1997 in areas of: Chronic inflammation, Autoimmunity, Microbiology & Probiotics, Cancer & Inflammation.

University lecturer, Lund University. Teaching immunology, for the advance and the basic courses (2001-current). Also started 3 new basic courses in immunology incorporated in different programs.

Specialties: Chronic inflammation, Autoimmune disorders e.g. Multiple Sclerosis, Rheumatoid Arthritis, Type 1 Diabetes and Sjogren┬┤s syndrome, Microbiology and probiotics: health benefits and related anti inflammatory effects, Biological markers, New drug target discovery, Drug delivery technology, Diagnosis, Cancer and inflammation.